Efficacy and safety of using eslicarbazepine in treating focal epilepsy in clinical practice (based on international Euro-Esli study and personal experience)
The latest data on the eslicarbazepine (ESL) efficacy, tolerability and safety in treatment of focal epilepsy are presented based on the results of the European study in clinical practice Euro-Esli that enrolled 2058 patients from 14 European centers, a detailed subgroup analysis, as well as our own...
Saved in:
Main Authors: | I. A. Zhidkova, V. A. Karlov, P. N. Vlasov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IRBIS LLC
2020-11-01
|
Series: | Эпилепсия и пароксизмальные состояния |
Subjects: | |
Online Access: | https://www.epilepsia.su/jour/article/view/590 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Real-World Efficacy and Tolerability of Switching from Oxcarbazepine to Eslicarbazepine Therapy in Children Aged 6 Years or Older with Focal Epilepsy
by: Sooyoung Lyu, et al.
Published: (2025-07-01) -
Update on the role of eslicarbazepine acetate in the treatment of partial-onset epilepsy
by: Tambucci R, et al.
Published: (2016-05-01) -
Modern possibilities of antiepileptic therapy at the start of treatment of focal epilepsy
by: P. N. Vlasov
Published: (2021-07-01) -
Epileptiform activity index for assessing oxcarbazepin therapy of newly-diagnosed focal epilepsy in adolescents and adults
by: V. A. Karlov, et al.
Published: (2020-11-01) -
COMPARATIVE EFFICАCY AND TOLERABILITY OF MONOTHERAPY WITH DEPAKINE CHRONOSPHERE, DRUGS OF CARBAMAZEPINE GROUP WITH EXTENDED RELEASE AND OXCARBAZEPINE IN SYMPTOMATIC AND CRYPTOGENIC FOCAL EPILEPSY (SVT. LUKA’S INSTITUTE OF CHILD NEUROLOGY AND EPILEPSY)
by: K. Yu. Mukhin, et al.
Published: (2015-04-01)